Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) – Equities research analysts at Jefferies Financial Group lowered their Q1 2023 earnings per share (EPS) estimates for shares of Prestige Consumer Healthcare in a research note issued to investors on Thursday, June 23rd. Jefferies Financial Group analyst S. Wissink now expects that the company will earn $1.03 per share for the quarter, down from their previous forecast of $1.05. Jefferies Financial Group currently has a “Buy” rating and a $70.00 target price on the stock. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.20 per share. Jefferies Financial Group also issued estimates for Prestige Consumer Healthcare’s Q2 2023 earnings at $1.04 EPS, Q3 2023 earnings at $1.06 EPS, FY2023 earnings at $4.18 EPS, Q1 2024 earnings at $1.07 EPS and Q3 2024 earnings at $1.12 EPS.
Several other analysts have also weighed in on the company. StockNews.com assumed coverage on Prestige Consumer Healthcare in a report on Thursday, March 31st. They set a “buy” rating on the stock. Oppenheimer raised Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 price objective on the stock in a research report on Monday, May 9th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average target price of $80.50.
NYSE:PBH opened at $58.90 on Friday. The stock’s fifty day moving average is $55.20 and its 200 day moving average is $56.85. Prestige Consumer Healthcare has a fifty-two week low of $50.40 and a fifty-two week high of $63.83. The firm has a market capitalization of $2.96 billion, a PE ratio of 14.03, a PEG ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.21 and a current ratio of 2.04.
Prestige Consumer Healthcare (NYSE:PBH – Get Rating) last released its quarterly earnings results on Thursday, May 5th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. Prestige Consumer Healthcare had a return on equity of 13.82% and a net margin of 18.90%. The company had revenue of $266.94 million for the quarter, compared to analyst estimates of $258.25 million. During the same quarter in the prior year, the firm posted $0.79 EPS. Prestige Consumer Healthcare’s quarterly revenue was up 12.3% compared to the same quarter last year.
A number of institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC bought a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth $26,000. Rockefeller Capital Management L.P. grew its position in shares of …